Laboratory Considerations for Clinical Trials
Science:Life Sciences
The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes that ecosystem and the lifecycle of patient samples.
She describes:
- The varying approaches of small vs. large laboratories
- Risks of insufficient tracking
- Tracking consent for future use
- Current practice and opportunities for improved tracking
Learn more at https://www.q2labsolutions.com/labmatrix
More Episodes
What is the Role of Digital Pathology in Clinical Trials
2023-11-17
202
2023-11-17
202
Flexible Approaches for Biotech Companies in Clinical Trials
2022-06-22
284
2022-06-22
284
Risk Management for Biotech Companies in Clinical Trials
2022-05-16
216
2022-05-16
216
Managing Sample Data from Vendors
2021-09-14
249
2021-09-14
249
Automation within an ADME Laboratory
2021-08-26
209
2021-08-26
209
Bioanalytical Automation of Samples
2021-07-30
183
2021-07-30
183
Consent Tracking for Clinical Samples
2021-07-28
185
2021-07-28
185
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
145
2021-02-02
145
Covid Vaccine Testing
2020-09-15
195
2020-09-15
195
Hybrid Assays for Protein Bioanalysis
2020-07-29
158
2020-07-29
158
High Throughput ADME Testing
2020-07-29
99
2020-07-29
99
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
145
2020-07-29
145
Get this podcast on your
phone, FREE
